Annual Drug Patent Expirations for FLOVENT+HFA
Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug.
FLOVENT HFA drug price trends.
Drug patent litigation for FLOVENT HFA.
This drug has thirty patent family members in fourteen countries.
The generic ingredient in FLOVENT HFA is fluticasone propionate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
